Knee Osteoarthritis Treatment With Peloidotherapy and Aquatic Exercise.

Knee Osteoarthritis Clinical Trial

Official title:

The Effectiveness of Peloidotherapy and Aquatic Exercise in Knee Osteoarthritis Treatment.

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05677399
• Other study ID #: 5000007
• Status: Completed
• Phase: N/A
• Start date: September 9, 2015
• Est. completion date: December 10, 2016

Study information

• Verified date: January 2023
• Source: Istanbul Arel University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The aim was to observe the short and medium term effects of peloidotherapy and aquatic exercise applications in patients with knee osteoarthritis.

Description:

Osteoarthritis (OA) is one of the most common musculoskeletal diseases in the world. It is a non-inflammatory chronic disease that starts from the articular cartilage and is characterized by mechanical wear and cartilage loss in the joints, and includes findings such as joint pain, stiffness, and limitation of movement. Its incidence increases with aging. OA is more common in the spine, hip, hand and knee joints. The knee, which is a load-bearing joint, is more affected. Knee osteoarthritis is one of the most common causes of disability. It is more common in women. The prevalence of symptomatic knee osteoarthritis in adults over the age of 55 was found to be 13% In the treatment guidelines, aquatic exercise and balneotherapy are among the recommendations for knee OA. Balneotherapy is a stimulus performed at a certain time interval and in a cure style, by using thermal and/or mineral waters, peloids (medical mud) and gases, in the form of bath, package, drinking and inhalation applications, whose methods and doses have been determined. compliance therapy. There are clinical studies showing that balneotherapy and mud pack applications reduce pain and increase functional capacity in knee osteoarthritis. Odabaşı et al. showed that peloidotherapy, one of the balneological methods, has not only thermic effect but also chemical effect in the treatment of knee OA. In patients with knee OA, pain, physical disability, quadriceps femoris muscle weakness and limitations in joint range of motion are observed. it reduces the level of physical activity, exercise capacity and quality of life in these people. The fact that the body is supported due to the buoyancy of the water in the exercises performed in the water reduces the load on the joints during the movement. For this reason, many movements that cannot be done on land can be done safely in water. On the other hand, because the density of water is higher than air, the muscles have to do more work even when performing a simple movement in water compared to the movements on land. Special rehabilitation programs based on water exercise programs have started to be one of the applications that can be done to increase muscle strength for these reasons.

When the literature was reviewed, we could not find any study examining the combination of aquatic exercise and peloid application in patients with knee osteoarthritis.

The aim of this study was to evaluate the effects of co-administration of peloid and aquatic exercises in knee osteoarthritis patients with a single-blind randomized controlled study.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 76
• Est. completion date: December 10, 2016
• Est. primary completion date: June 10, 2016
• Accepts healthy volunteers: No
• Gender: All
• Age group: 40 Years to 75 Years

Eligibility

Inclusion Criteria:

• primary knee osteoarthritis diagnosed according to the ACR criteria

• gave their written informed consent

• 40-75 ages

• Kellgren Lawrence grading 2-4

• having symptomatic knee pain at least 3 months.

Exclusion Criteria:

• secondary knee OA

• pathology of the waist, hip, or ankle joints

• decompensated organ failure

• malignancy,

• active bleeding

• infectious disease

• serious knee injuries or previous surgical procedures within the past 6 months

• the use of intraarticular steroids and hyaluronic acid injection to the knee joint within the past 6 months

• physiotherapy, balneotherapy, or peloidotherapy within the past 1 year.

Related Conditions & MeSH terms

• Knee Osteoarthritis
• Osteoarthritis
• Osteoarthritis, Knee

Intervention

Other:
• aquatic exercise and peloidotherapy
Treatment group received 30 minutes of aquatic exercise by a physiotherapist in a warmed up to 33° C tap water and 30 minutes of mud pack treatment at 42°C on both knees 5 weekdays for 2 consecutive weeks (totally 10 sessions).

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Istanbul Arel University

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Pain (VAS)	The VAS is a commonly used scale which determines the intensity of pain. It consists of a 10-cm long line, drawn horizontally Numeric value (in cm between 0 and 10) of patients' pain intensity was determined by measuring the distance between the lowest VAS value and patients' marks.	Change from baseline pain (VAS) at the end of the treatment, 1 month after treatment ,3 months after treatment.
Primary	WOMAC (total)	The WOMAC Scale is a commonly used well-being scale for patients with knee or hip OA. It consists of three main sections: pain, stiffness, and physical function. It contains a total of 24 items. Scoring of these items is done according to the Likert scale. In the Likert scale, patients indicate pain and difficulty levels by giving scores between 0 and 4. Turkish validity and reliability study had been conducted for WOMAC	Change from baseline WOMAC scores at the end of the treatment, 1 month after treatment ,3 months after treatment.
Secondary	IGA (VAS)	Investivagors' Global Assessment. The VAS is a commonly used scale which determines the intensity of pain. It consists of a 10-cm long line, drawn horizontally Numeric value (in cm between 0 and 10) of patients' pain intensity was determined by measuring the distance between the lowest VAS value and patients' marks.Also is used to assess the patients' global and physicians' global assessment.	Change from baseline IGA (VAS) at the end of the treatment, 1 month after treatment ,3 months after treatment.
Secondary	PGA (VAS)	Patients' Global Assessment. The VAS is a commonly used scale which determines the intensity of pain. It consists of a 10-cm long line, drawn horizontally Numeric value (in cm between 0 and 10) of patients' pain intensity was determined by measuring the distance between the lowest VAS value and patients' marks.Also is used to assess the patients' global and physicians' global assessment.	Change from baseline PGA (VAS) at the end of the treatment, 1 month after treatment ,3 months after treatment.
Secondary	WOMAC (pain)	The WOMAC Scale is a commonly used well-being scale for patients with knee or hip OA. It consists of three main sections: pain, stiffness, and physical function. It contains a total of 24 items. Scoring of these items is done according to the Likert scale. In the Likert scale, patients indicate pain and difficulty levels by giving scores between 0 and 4. Turkish validity and reliability study had been conducted for WOMAC.	Change from baseline WOMAC (pain) scores at the end of the treatment, 1 month after treatment ,3 months after treatment.
Secondary	WOMAC (stiffness)	The WOMAC Scale is a commonly used well-being scale for patients with knee or hip OA. It consists of three main sections: pain, stiffness, and physical function. It contains a total of 24 items. Scoring of these items is done according to the Likert scale. In the Likert scale, patients indicate pain and difficulty levels by giving scores between 0 and 4. Turkish validity and reliability study had been conducted for WOMAC.	Change from baseline WOMAC (stiffness) scores at the end of the treatment, 1 month after treatment ,3 months after treatment.
Secondary	WOMAC (physical function)	The WOMAC Scale is a commonly used well-being scale for patients with knee or hip OA. It consists of three main sections: pain, stiffness, and physical function. It contains a total of 24 items. Scoring of these items is done according to the Likert scale. In the Likert scale, patients indicate pain and difficulty levels by giving scores between 0 and 4. Turkish validity and reliability study had been conducted for WOMAC.	Change from baseline WOMAC (physical function) at the end of the treatment, 1 month after treatment ,3 months after treatment.
Secondary	LAFI	LAFI is used to determine the pain and functional severity of knee and hip OA with three parts of pain, maximum walk distance and some activities of daily living. It has 11 questions of total score of 0 to 24 that higher scores shows more involvement	Change from baseline LAFI at the end of the treatment, 1 month after treatment ,3 months after treatment.
Secondary	HAQ	HAQ is used to evaluate functional disability status of patients in eight subscales; dressing, rising, eating, walking, hygiene, reach, grip and usual activities. It includes 20 items and each item has 3 likert score which 0 to 3 where 3 is unable to do	Change from baseline HAQ at the end of the treatment, 1 month after treatment ,3 months after treatment.
Secondary	SF-36	The SF-36 Health Survey is a comprehensive measurement tool used to evaluate non-disease-specific overall quality of life. It has been developed and made available by Rand Corporation in order to evaluate overall quality of life (). It contains a total of 36 items with eight subscales: physical functioning, role-physical, role-emotional, bodily pain, social functioning, mental health, vitality, and general health. It grades the patient by using scores between 0 and 100,0 indicating poor health while 100 indicating good health. Turkish validity and reliability study had been con¬ducted for SF-36	Change from baseline SF-36 at the end of the treatment, 1 month after treatment ,3 months after treatment.
Secondary	Timed Up and Go Test	TUG is a valid and reliable functional mobility test. It has a correlation with lower extremity strength and useful for identifying older adults risk of falling	Change from baseline TUG at the end of the treatment, 1 month after treatment ,3 months after treatment.